One finding supported by human postmortem and neuroimaging studies is that there are lower levels of muscarinic M1 receptors (CHRM1) in the cortex of patients with schizophrenia6 and that the cognitive deficits experienced by patients with schizophrenia are related to the levels of that receptor7. This evidence concerns the gene CHRM1 and Cognitive impairment.